Supplemental l-arginine during cardioplegic arrest and reperfusion avoids regional postischemic injury
- 1 August 1995
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 110 (2) , 302-314
- https://doi.org/10.1016/s0022-5223(95)70226-1
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Pentostatin-augmented interstitial adenosine prevents postcardioplegia injury in damaged heartsThe Annals of Thoracic Surgery, 1994
- Coronary artery endothelial dysfunction after global ischemia, blood cardioplegia, and reperfusionThe Annals of Thoracic Surgery, 1994
- Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion of dogs.Circulation, 1993
- Endothelial and Myocardial Cell Protection by a Cysteine-Containing Nitric Oxide Donor After Myocardial Ischemia and ReperfusionJournal of Cardiovascular Pharmacology, 1993
- Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemiaThe FASEB Journal, 1991
- Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat.Circulation, 1990
- L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxationBiochemical and Biophysical Research Communications, 1988
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Endothelium‐derived relaxing factor inhibits in vitro platelet aggregationBritish Journal of Pharmacology, 1987
- Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factorNature, 1986